
### [NCIT:C2926](http://purl.obolibrary.org/obo/NCIT_C2926)
**Label:** Non-Small Cell Lung Carcinoma

**Subclasses:** [NCIT:C8759](http://purl.obolibrary.org/obo/NCIT_C8759) (Stage I Lung Adenocarcinoma AJCC v7), [NCIT:C5649](http://purl.obolibrary.org/obo/NCIT_C5649) (Acinar Lung Adenocarcinoma), [NCIT:C8757](http://purl.obolibrary.org/obo/NCIT_C8757) (Recurrent Lung Adenocarcinoma), [NCIT:C8758](http://purl.obolibrary.org/obo/NCIT_C8758) (Stage 0 Lung Adenocarcinoma AJCC v6 and v7), [NCIT:C8755](http://purl.obolibrary.org/obo/NCIT_C8755) (Stage I Large Cell Lung Carcinoma AJCC v7), [NCIT:C8756](http://purl.obolibrary.org/obo/NCIT_C8756) (Stage IV Large Cell Lung Carcinoma AJCC v7), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C8753](http://purl.obolibrary.org/obo/NCIT_C8753) (Recurrent Large Cell Lung Carcinoma), [NCIT:C7266](http://purl.obolibrary.org/obo/NCIT_C7266) (Basaloid Large Cell Lung Carcinoma), [NCIT:C7783](http://purl.obolibrary.org/obo/NCIT_C7783) (Recurrent Non-Small Cell Lung Carcinoma), [NCIT:C8751](http://purl.obolibrary.org/obo/NCIT_C8751) (Stage III Adenosquamous Lung Carcinoma AJCC v7), [NCIT:C7268](http://purl.obolibrary.org/obo/NCIT_C7268) (Minimally Invasive Mucinous Lung Adenocarcinoma), [NCIT:C8752](http://purl.obolibrary.org/obo/NCIT_C8752) (Stage IV Adenosquamous Lung Carcinoma AJCC v7), [NCIT:C136490](http://purl.obolibrary.org/obo/NCIT_C136490) (Lung Adenocarcinoma by AJCC v7 Stage), [NCIT:C136491](http://purl.obolibrary.org/obo/NCIT_C136491) (Non-Small Cell Lung Cancer by AJCC v7 Stage), [NCIT:C8750](http://purl.obolibrary.org/obo/NCIT_C8750) (Stage II Adenosquamous Lung Carcinoma AJCC v7), [NCIT:C136492](http://purl.obolibrary.org/obo/NCIT_C136492) (Adenosquamous Lung Carcinoma by AJCC v7 Stage), [NCIT:C136493](http://purl.obolibrary.org/obo/NCIT_C136493) (Large Cell Lung Carcinoma by AJCC v7 Stage), [NCIT:C35758](http://purl.obolibrary.org/obo/NCIT_C35758) (Stage 0 Large Cell Lung Carcinoma AJCC v6 and v7), [NCIT:C133254](http://purl.obolibrary.org/obo/NCIT_C133254) (Non-Small Cell Squamous Lung Carcinoma), [NCIT:C3512](http://purl.obolibrary.org/obo/NCIT_C3512) (Lung Adenocarcinoma), [NCIT:C5650](http://purl.obolibrary.org/obo/NCIT_C5650) (Papillary Lung Adenocarcinoma), [NCIT:C5651](http://purl.obolibrary.org/obo/NCIT_C5651) (Solid Lung Adenocarcinoma), [NCIT:C8762](http://purl.obolibrary.org/obo/NCIT_C8762) (Stage IV Lung Adenocarcinoma AJCC v7), [NCIT:C9257](http://purl.obolibrary.org/obo/NCIT_C9257) (Stage III Large Cell Lung Carcinoma AJCC v7), [NCIT:C136486](http://purl.obolibrary.org/obo/NCIT_C136486) (Lung Adenocarcinoma In Situ), [NCIT:C8760](http://purl.obolibrary.org/obo/NCIT_C8760) (Stage II Lung Adenocarcinoma AJCC v7), [NCIT:C8761](http://purl.obolibrary.org/obo/NCIT_C8761) (Stage III Lung Adenocarcinoma AJCC v7), [NCIT:C6660](http://purl.obolibrary.org/obo/NCIT_C6660) (Stage II Large Cell Lung Carcinoma AJCC v7), [NCIT:C9133](http://purl.obolibrary.org/obo/NCIT_C9133) (Adenosquamous Lung Carcinoma), [NCIT:C45540](http://purl.obolibrary.org/obo/NCIT_C45540) (Lung Sarcomatoid Carcinoma), [NCIT:C6876](http://purl.obolibrary.org/obo/NCIT_C6876) (Large Cell Lung Carcinoma with Rhabdoid Phenotype), [NCIT:C136710](http://purl.obolibrary.org/obo/NCIT_C136710) (Lung Enteric Adenocarcinoma), [NCIT:C45542](http://purl.obolibrary.org/obo/NCIT_C45542) (Lung Pleomorphic Carcinoma), [NCIT:C4450](http://purl.obolibrary.org/obo/NCIT_C4450) (Large Cell Lung Carcinoma), [NCIT:C4451](http://purl.obolibrary.org/obo/NCIT_C4451) (Large Cell Lung Carcinoma, Clear Cell Variant), [NCIT:C45541](http://purl.obolibrary.org/obo/NCIT_C45541) (Lung Spindle Cell Carcinoma), [NCIT:C4452](http://purl.obolibrary.org/obo/NCIT_C4452) (Lung Giant Cell Carcinoma), [NCIT:C4012](http://purl.obolibrary.org/obo/NCIT_C4012) (Stage IV Non-Small Cell Lung Cancer AJCC v7), [NCIT:C9104](http://purl.obolibrary.org/obo/NCIT_C9104) (Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7), [NCIT:C45543](http://purl.obolibrary.org/obo/NCIT_C45543) (Lung Carcinosarcoma), [NCIT:C45502](http://purl.obolibrary.org/obo/NCIT_C45502) (Squamous Cell Lung Carcinoma, Papillary Variant), [NCIT:C6671](http://purl.obolibrary.org/obo/NCIT_C6671) (Stage I Non-Small Cell Lung Cancer AJCC v7), [NCIT:C45503](http://purl.obolibrary.org/obo/NCIT_C45503) (Squamous Cell Lung Carcinoma, Clear Cell Variant), [NCIT:C45509](http://purl.obolibrary.org/obo/NCIT_C45509) (Fetal Lung Adenocarcinoma), [NCIT:C136716](http://purl.obolibrary.org/obo/NCIT_C136716) (Non-Mucinous Lung Adenocarcinoma In Situ), [NCIT:C136717](http://purl.obolibrary.org/obo/NCIT_C136717) (Mucinous Lung Adenocarcinoma In Situ), [NCIT:C3732](http://purl.obolibrary.org/obo/NCIT_C3732) (Pulmonary Blastoma), [NCIT:C8748](http://purl.obolibrary.org/obo/NCIT_C8748) (Stage 0 Adenosquamous Lung Carcinoma AJCC v6 and v7), [NCIT:C8749](http://purl.obolibrary.org/obo/NCIT_C8749) (Stage I Adenosquamous Lung Carcinoma AJCC v7), [NCIT:C7777](http://purl.obolibrary.org/obo/NCIT_C7777) (Stage II Non-Small Cell Lung Cancer AJCC v7), [NCIT:C8747](http://purl.obolibrary.org/obo/NCIT_C8747) (Recurrent Adenosquamous Lung Carcinoma), [NCIT:C7778](http://purl.obolibrary.org/obo/NCIT_C7778) (Stage III Non-Small Cell Lung Cancer AJCC v7), [NCIT:C5672](http://purl.obolibrary.org/obo/NCIT_C5672) (Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C45512](http://purl.obolibrary.org/obo/NCIT_C45512) (Lung Colloid Adenocarcinoma), [NCIT:C36054](http://purl.obolibrary.org/obo/NCIT_C36054) (Biphasic Pulmonary Blastoma), [NCIT:C36053](http://purl.obolibrary.org/obo/NCIT_C36053) (Epithelial Predominant Pulmonary Blastoma), [NCIT:C45519](http://purl.obolibrary.org/obo/NCIT_C45519) (Lymphoepithelioma-Like Lung Carcinoma), [NCIT:C2923](http://purl.obolibrary.org/obo/NCIT_C2923) (Minimally Invasive Lung Adenocarcinoma), [NCIT:C118814](http://purl.obolibrary.org/obo/NCIT_C118814) (Childhood Non-Small Cell Lung Carcinoma), [NCIT:C123160](http://purl.obolibrary.org/obo/NCIT_C123160) (Lepidic Predominant Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C98357](http://purl.obolibrary.org/obo/NCIT_C98357) (EGFR Gene Mutation) 62.50%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 62.50%
- [NCIT:C17757](http://purl.obolibrary.org/obo/NCIT_C17757) (EGFR Gene) 62.50%
- Thing 51.30%
- [NCIT:C36795](http://purl.obolibrary.org/obo/NCIT_C36795) (Malignant Epithelial Small Cell) 32.91%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 30.14%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 30.00%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 28.13%
- [NCIT:C20719](http://purl.obolibrary.org/obo/NCIT_C20719) (Receptor Tyrosine Kinase Gene) 26.37%
- [NCIT:C36334](http://purl.obolibrary.org/obo/NCIT_C36334) (Tumor-Suppressor Gene Inactivation) 23.41%
- [NCIT:C20103](http://purl.obolibrary.org/obo/NCIT_C20103) (Receptor Gene) 23.16%
- [NCIT:C21295](http://purl.obolibrary.org/obo/NCIT_C21295) (Ligand Binding Protein Gene) 21.78%
- [NCIT:C97927](http://purl.obolibrary.org/obo/NCIT_C97927) (Gene Mutant) 20.72%
- [NCIT:C21281](http://purl.obolibrary.org/obo/NCIT_C21281) (Enzyme Gene) 20.31%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 16.62%


